High-dose melphalan followed by autograft employing non-cryopreserved peripheral blood progenitor cells in children

European Journal of Cancer Part A

Volumn 32, Issue 11, 1996, Pages 1938-1942

  Jones, N ^a   Williams, D ^a   Broadbent, V ^a   Jestice, K ^a   Boraks, P ^a   Scott, M ^a   Ager, S ^a   Marcus, R ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

ABMT; CFU GM; Children; Cyclophosphamide; Leukapheresis; Melphalan; Mononuclear cell; PBPC

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ADOLESCENT; ARTICLE; AUTOGRAFT; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0030272387     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00209-2     Document Type: Article

References (17)

1. 1. Ladenstein R, Hartmann O, Pinkerton CR. The role of megatherapy with autologous bone marrow rescue in solid tumours of childhood. Ann Oncol 1993, 4, S45-S58.
2. 2. To LB, Roberts MM, Haylock DN, et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants and allogeneic bone marrow transplants. Bone Marrow Transplantation 1992, 9, 277-284.
3. 3. Henon Ph, Liang H, Beck-Wirth G, et al. Comparison of haematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplantation 1992, 9, 285-291.
4. 4. Uyl-de Groot CA, Richel DJ, Rutten FFH. Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (Filgrastim); a less costly alternative to autologous bone marrow transplantation. Eur J Cancer 1994, 30A, 1631-1635.
5. 5. Watanabe T, Takaue Y, Kawano Y, et al. Peripheral blood stem cell autotransplantation in treatment of childhood cancer. Bone Marrow Transplantation 1989, 4, 261-265.
6. 6. Lasky CL, Bostrom B, Smith J, et al. Clinical collection and use of peripheral blood stem cells in paediatric patients. Transplantation 1989, 4, 613-616.
7. 7. Siena S, Bregni M, Brando B, et al. Circulation of CD34+ haematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989, 74, 1905-1914.
8. 8. Sicinski MA, Cannistra SA, Elias A, et al. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988, i, 1194-1198.
9. 9. Fukuda M, Kojima A, Matsumoto K, et al. Autotransplantation of peripheral blood stem cells mobilized by chemotherapy and recombinant human granulocyte colony stimulating factor in childhood neuroblastoma and non-Hodgkins lymphoma. Br J Haematol 1992, 80, 327-331.
10. 10. Ash RC, Detrick RA, Zanjani ED. Studies of human pluripotential haematopoietic stem cells (CFU-GEMM) in vitro. Blood 1981, 58, 309-322.
11. 11. Takaue Y, Watanabe T, Kawano Y, et al. Isolation and storage of peripheral blood haematopoietic stem cells for autotransplantation into children with cancer. Blood 1989, 74, 1245-1251.
12. 12. Takaue Y. Peripheral blood stem cell autografts in children with acute lymphoblastic lymphoma: updated experience. Leuk Lymphoma 1991, 3, 241-256.
13. 13. Jestice HK, Scott MA, Ager S, et al. Liquid storage of peripheral blood progenitor cells for transplantation. Bone Marrow Transplantation 1994, 14, 991-994.
14. 2 cyclophosphamide for peripheral blood stem cell mobilisation. Int J Cell Cloning 1992, 10(5), 33-34.
15. 15. Kotasek D, Shepherd KM, Sage RE, et al. Factors affecting blood stem cell collection following high-dose cyclophosphamide mobilisation in lymphoma, myeloma and solid tumors. Bone Marrow Transplantation 1992, 9, 11-17.
16. 16. Mitchell PL, Shepherd VB, Proctor HM, et al. Peripheral blood stem cells used to augment autologous bone marrow transplantation. Arch Dis Child 1994, 70, 237-240.
17. 17. Shea TC, Mason JR, Storniolo AM, et al. Sequential cycles of high dose carboplatin administered with recombinant human granulocyte-macrophage colony/stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy. J Clin Oncol 1992, 10, 464-473.